drugset / Trial / NCT04996134

Domperidone Expanded Access Treatment Program

NCT04996134

Expanded access No longer available Wake Forest University Health Sciences

Summary

To allow the use of domperidone by patients with gastrointestinal disorders who have failed standard therapy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg Oral
Subject Domperidone Unknown 30 mg Oral

Indications